Moleculin Biotech (MBRX) Stock Chart & Stock Price History → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free MBRX Stock Alerts $5.91 +0.37 (+6.68%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Moleculin Biotech Stock Price Performance5 Day Performance+3.60%1 Month Performance-35.40%3 Month Performance-47.47%6 Month Performance-6.86%Year-To-Date Performance-54.10%1 Year Performance-58.51% Receive MBRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… MBRX Stock Chart for Friday, March, 29, 2024 MBRX Chart by TradingView Moleculin Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$5.54$5.91+6.68%$6.23$5.1877,998 shs$13.18 million03/27/2024$4.68$5.54+18.38%$5.69$4.7589,236 shs$12.35 million03/26/2024$5.25$4.68-10.86%$4.99$4.3491,056 shs$10.44 million03/25/2024$5.70$5.25-7.97%$6.00$4.65915,017 shs$11.70 million03/22/2024$6.63$5.70-13.96%$6.24$5.3097,562 shs$190.59 million03/21/2024$6.31$6.63+5.09%$7.34$6.1144,320 shs$14.77 million Get the Latest News and Ratings for MBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$7.86$6.31-19.70%$7.80$6.0064,901 shs$14.05 million03/19/2024$8.25$7.86-4.76%$8.85$7.865,974 shs$17.50 million03/18/2024$7.42$8.25+11.22%$8.55$8.257,085 shs$18.38 million03/15/2024$8.03$7.42-7.67%$8.40$7.208,272 shs$16.52 million03/14/2024$8.41$8.03-4.43%$8.70$7.3512,932 shs$17.89 million03/13/2024$8.42$8.41-0.12%$8.70$8.402,698 shs$18.72 million03/12/2024$9.48$8.42-11.22%$9.47$8.4013,008 shs$18.75 million03/11/2024$10.11$9.48-6.25%$10.35$9.302,779 shs$21.12 million03/08/2024$10.05$10.11+0.61%$10.35$9.904,945 shs$22.52 million03/07/2024$10.05$10.05$10.16$9.515,557 shs$22.39 million03/06/2024$10.11$10.05-0.59%$10.20$9.905,196 shs$22.39 million03/05/2024$10.32$10.11-2.03%$10.32$9.907,840 shs$22.52 million03/04/2024$9.17$10.32+12.60%$10.35$9.0218,036 shs$22.99 million03/01/2024$9.44$9.17-2.86%$9.75$8.858,335 shs$20.41 million02/29/2024$9.15$9.44+3.13%$9.50$8.933,849 shs$21.02 million02/28/2024$9.24$9.15-0.99%$9.26$8.706,372 shs$20.38 million02/27/2024$8.84$9.24+4.58%$9.64$8.5512,522 shs$20.58 million02/26/2024$8.10$8.84+9.11%$8.84$8.067,614 shs$19.68 million02/23/2024$7.73$8.10+4.82%$8.10$7.379,545 shs$18.04 million02/22/2024$7.22$7.73+7.05%$7.73$7.353,576 shs$17.21 million02/21/2024$7.50$7.22-3.76%$7.64$7.174,838 shs$16.07 million02/20/2024$7.46$7.50+0.48%$7.74$7.202,697 shs$16.70 million02/19/2024$7.46$7.46$7.80$7.207,167 shs$16.62 million02/16/2024$7.50$7.46-0.50%$7.80$7.207,170 shs$16.62 million02/15/2024$7.65$7.50-1.92%$8.10$7.352,381 shs$16.71 million02/14/2024$7.65$7.65-0.04%$7.80$7.204,216 shs$17.03 million02/13/2024$7.76$7.65-1.35%$8.02$7.274,040 shs$17.04 million02/12/2024$7.75$7.76+0.08%$8.42$7.755,120 shs$17.27 million02/09/2024$7.40$7.75+4.79%$7.76$7.222,821 shs$17.26 million02/08/2024$7.80$7.40-5.19%$7.79$7.208,998 shs$16.47 million02/07/2024$7.68$7.80+1.50%$7.80$7.127,812 shs$17.37 million02/06/2024$7.79$7.68-1.29%$8.40$7.249,206 shs$17.12 million02/05/2024$7.60$7.79+2.43%$7.80$7.363,865 shs$17.34 million02/02/2024$7.76$7.60-1.99%$7.71$7.514,615 shs$16.93 million“The Stock Market’s Bull Run is Far from Over” -Barrons (Ad)Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… 02/01/2024$7.56$7.76+2.58%$7.80$7.347,515 shs$17.27 million01/31/2024$7.56$7.56$7.58$7.205,454 shs$16.84 million01/30/2024$7.35$7.56+2.86%$7.80$6.904,854 shs$16.84 million01/29/2024$7.29$7.35+0.82%$7.95$7.206,276 shs$16.37 million01/26/2024$7.31$7.29-0.31%$7.74$7.202,584 shs$16.24 million01/25/2024$7.61$7.31-3.88%$7.71$7.0512,123 shs$16.29 million01/24/2024$6.85$7.61+11.08%$8.07$7.3534,907 shs$16.95 million01/23/2024$7.53$6.85-9.10%$8.02$6.7122,312 shs$15.26 million01/22/2024$8.20$7.53-8.16%$8.70$7.4625,385 shs$16.78 million01/19/2024$8.28$8.20-0.89%$8.70$7.6712,047 shs$18.27 million01/18/2024$9.42$8.28-12.11%$9.90$7.6727,755 shs$16.45 million01/17/2024$9.89$9.42-4.81%$10.31$9.2915,976 shs$18.72 million01/16/2024$10.65$9.89-7.11%$11.10$9.6017,110 shs$19.66 million01/15/2024$10.65$10.65$10.80$10.521,273 shs$21.17 million01/12/2024$10.66$10.65-0.06%$10.80$10.521,209 shs$21.17 million01/11/2024$11.22$10.66-5.03%$11.17$10.505,062 shs$21.18 million01/10/2024$11.28$11.22-0.53%$11.55$10.743,679 shs$22.30 million01/09/2024$10.79$11.28+4.59%$11.69$10.467,683 shs$22.42 million01/08/2024$12.60$10.79-14.44%$12.90$10.2318,243 shs$21.43 million01/05/2024$13.65$12.60-7.66%$13.50$12.218,050 shs$25.05 million01/04/2024$14.25$13.65-4.20%$14.70$10.8722,066 shs$27.13 million01/03/2024$13.86$14.25+2.79%$15.75$13.4325,711 shs$28.32 million01/02/2024$12.88$13.86+7.65%$14.09$12.7219,952 shs$27.55 million01/01/2024$12.88$12.88$12.99$11.5532,507 shs$25.59 million12/29/2023$11.25$12.88+14.45%$12.99$11.5532,338 shs$25.59 million12/28/2023$10.65$11.25+5.63%$11.70$10.8026,652 shs$22.36 million12/27/2023$9.72$10.65+9.58%$11.25$10.0049,580 shs$21.17 million Related Companies: INDP Stock Chart NCNA Stock Chart CNTX Stock Chart PPBT Stock Chart MIRA Stock Chart ONTX Stock Chart FBIO Stock Chart NERV Stock Chart SYBX Stock Chart XLO Stock Chart Receive MBRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MBRX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moleculin Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.